But how would you know there is no material difference and only immaterial changes? I don't think sgh is out there to decieve, but even the best can make bad investment decisions, and in this is just imo that sgh has overpaid for the psd, and generally shorters has inside information.
As someone had already pointed it out, this year in the last 5 years the interval days between prelim accounts and stat has been by far the longest, and arguably the most important year to date that they have to assure shareholders their accounts are in order.
In the long run, I think sgh is a good buy, but just saying anything can happen and even the best companies can make awful decisions.
- Forums
- ASX - By Stock
- SGH
- Buy
Buy, page-164
Featured News
Add SGH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online